Table 1 Patient characteristics at baseline and during ICU stay—derivation cohort
Baseline patient characteristics (n = 255) | |
|---|---|
Age (years, mean ± SD) | 64 ± 15 |
Male, n (%) | 168 (65.9) |
Medical history, n (%) | |
Ulcer | 29 (11.4) |
Cirrhosis | 45 (17.6) |
Esophageal varices | 5 (2) |
Cardiovascular comorbidity | 134 (52.5) |
CKD | 33 (12.9) |
Chronic RRT | 7 (2.7) |
Cancer/hematological malignancies | 81 (31.8) |
Digestive surgery | 64 (25.1) |
Diabetes mellitus | 51 (20) |
COPD/asthma | 31 (12.2) |
HIV | 6 (2.4) |
Medication, n (%) | |
Antiplatelet drugs | 71 (27.8) |
Anticoagulants | 47 (18.5) |
NSAIDs | 14 (5.5) |
Steroids | 32 (12.6) |
Chemotherapy | 29 (11.4) |
PPIs | 83 (32.7) |
ICU admission cause, n (%) | |
Sepsis/septic shock | 57 (22.4) |
Cardiac arrest/cardiogenic shock | 13 (5.1) |
Respiratory | 90 (35.3) |
Neurologic | 42 (16.5) |
Metabolic | 26 (10.2) |
Others | 27 (10.6) |
Admission SAPSII (mean ± SD) | 51 ± 19 |
ICU stay characteristics and treatment, n (%) | |
Sepsis | 170 (66.7) |
Invasive mechanical ventilation | 191 (74.9) |
RRT | 87 (34.1) |
Vasopressors | 144 (56.4) |
Anticoagulant | 71 (27.8) |
Steroids | 54 (21.2) |
Antiplatelets | 52 (20.4) |
Outcome | |
ICU LOS (days, mean ± SD) | 17.5 ± 17.6 |
Hospital LOS (days, mean ± SD) | 35 ± 34.5 |
In-ICU mortality, n (%) | 70 (27.4) |
In-hospital mortality, n (%) | 87 (34.1) |